A prospective, multi-center pivotal study of the LUM imaging system for real-time, in vivo margin assessment in breast conserving surgery

Ended Project Grant Awarded Sep 18, 2017 Last action Nov 5, 2024

Award ID: R01CA212138
Recipient: The General Hospital Corporation UEI FLJ7DQKLL226
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $3,657,838

Award facts

Award details come from USAspending.gov.

Action	Federal	Non-federal	Date
Amendment	-$70	$0	Nov 5, 2024
Amendment	$0	$0	Sep 18, 2023
Amendment	$1,055,716	$0	Jun 30, 2022
Amendment	$1,055,716	$0	Jun 30, 2022
Amendment	$274,299	$0	Aug 25, 2021
Amendment	$274,299	$274,299	Aug 25, 2021
Amendment	$0	$0	Aug 26, 2020
Amendment	$0	$0	Aug 26, 2019
Amendment	$0	$0	Sep 3, 2018
Original award	$723,579	$0	Sep 18, 2017

Subrecipient	Amount	Awarded
Lumicell Inc. Lumicell will hold the IDE required from FDA to conduct this study using the LUM Imaging System and will be the regulatory sponsor for this clinical study.…	$344,202	May 10, 2022
Duke University The Principal Investigator for the proposed work at Duke University Medical Center is Dr. Shelley Hwang. Personnel at Duke University Medical Center will…	$247,905	Aug 10, 2021
The Leland Stanford Junior University The Principal Investigator, for the proposed work at Stanford University School of Medicine (SUSM) is Dr. Irene Wapnir. Personnel at SUSM will recruit…	$343,859	Jun 22, 2021
The Univeristy Of Texas M.d. Anderson Cancer Center The Principal Investigator, for the proposed work at The University of Texas MD Anderson Cancer Center (UTMDACC) is Dr. Kelly Hunt, an employee of the…	$228,491	May 3, 2021

R01CA212138 was awarded to The General Hospital Corporation by National Cancer Institute (National Institutes of Health) on September 18, 2017.

$3,657,838 has been obligated on R01CA212138: $3,383,539 in federal funding and $274,299 in non-federal funding.

On GovTribe

Try for free Login